Delivering the unexpected—Information needs for PSA screening from Men's perspective: A qualitative study

Delivering the unexpected—Information needs for PSA screening from Men's perspective: A qualitative study

Abstract Background Making decisions about PSA screening tests is challenging, as it requires both knowledge of the possible benefits and harms of screening and an individual assessment of the patient's values. Our research explores how much and what information men perceive to be necessary wit...

Full description

Bibliographic Details
Main Authors:	Katrin Kuss, Charles Christian Adarkwah, Miriam Becker, Norbert Donner‐Banzhoff, Kathrin Schloessler
Format:	Article
Language:	English
Published:	Wiley 2021-08-01
Series:	Health Expectations
Subjects:	consumer health information counselling decision aid prostate‐specific antigen (PSA) qualitative research shared decision making
Online Access:	https://doi.org/10.1111/hex.13275

Similar Items

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
by: Ulrika Rönningås, et al.
Published: (2019-07-01)

Evaluation of serum PSA levels as a biomarker for breast carcinoma in north Indian females
by: Nikhil Gupta
Published: (2014-05-01)

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-08-01)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01)

Barriers and facilitators of shared decision-making in prostate cancer screening in primary care: A systematic review
by: María Estevan-Vilar, et al.
Published: (2024-01-01)

SIGNIFICANCE OF DETECTION OF FREE/TOTAL PSA RATIO AND OTHER BIOCHEMICAL PARAMETERS IN PATIENTS WITH BPH, CARCINOMA PROSTATE AND ITS CLINICOPATHOLOGIC CORRELATION
by: S. Joshi, et al.
Published: (2021-11-01)

Association between PSA and age in Macuxi ethnic population of the Brazilian Amazon forest region
by: de Lima Junior MM, et al.
Published: (2018-10-01)

Predictive value of PSA density in the diagnosis of prostate cancer in lebanese men
by: Ali Msheik, et al.
Published: (2022-03-01)

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
by: O. Üçer, et al.
Published: (2017-06-01)

Predictive Parameters on the Effect of Ofloxacin Treatment on the Reduction of PSA in Patients With Elevated PSA Level
by: Kerem TEKE, et al.
Published: (2019-10-01)

Association between gleason score, psa level, PSAD and prostate volume, in a series of patients with prostate adenocarcinoma
by: Benedetti-Padrón Inés, et al.
Published: (2012-06-01)

The effect of green tea on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials
by: Elham Sharifi-Zahabi, et al.
Published: (2021-03-01)

The clinical impact of WHO standardization of PSA assays
by: Blanchet Jean-Sébastien, et al.
Published: (2008-01-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

Fostering shared decision-making about prostate cancer screening among African American men patients and their primary care providers: a randomized behavioral clinical trial
by: Margarita Echeverri, et al.
Published: (2022-08-01)

Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosis
by: Tasneem Khan, et al.
Published: (2022-10-01)

The effect of a new lifetime-cardiovascular-risk display on patients’ motivation to participate in shared decision-making
by: Nikita Roman A. Jegan, et al.
Published: (2018-06-01)

Comparison of Pathology and Prevalence of Prostate Cancer in Patients with PSA between 4-10 ng/ml
by: A Tabibi, et al.
Published: (2008-01-01)

Clinical application of p2PSA and its derivatives (%p2PSA and Phi) in the diagnosis of prostate cancer
by: Weiwang Cai, et al.
Published: (2023-11-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
by: Michael H. Johnson, et al.
Published: (2015-09-01)

Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy
by: Bakheet E.M. Elsadek, et al.
Published: (2021-07-01)

URINARY RETENTION EFFECT IN THE INCREASED OF PSA EXPRESSION WITHIN PROSTATIC TISSUE
by: Wahjoe Djatisoesanto, et al.
Published: (2015-10-01)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
by: Rie von Eyben, et al.
Published: (2023-08-01)

Utilisation and impact of predict prostate on decision‐making among clinicians and patients in a specialist tertiary referral centre: A retrospective cohort study
by: Madhumitha Pandiaraja, et al.
Published: (2024-04-01)

Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model
by: Francesco Gentile, et al.
Published: (2021-02-01)

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
by: Samuel W. D. Merriel, et al.
Published: (2022-02-01)

Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers
by: Danil V. Makarov, et al.
Published: (2021-02-01)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-03-01)

A New Interpretation of the Standard PSA-Test
by: Esteban EP, et al.
Published: (2020-03-01)

Free PSA: A better molecular marker than total PSA for breast cancer
by: Rachita Nanda
Published: (2014-10-01)

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

Serum and urinary measurements of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in dogs Mensurações sérica e urinária de fosfatase ácida prostática e antígeno prostático específico em cães
by: R.L. Amorim, et al.
Published: (2004-06-01)

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care
by: Anita D. Misra-Hebert, et al.
Published: (2018-06-01)

Total PSA and free PSA in patients with severe liver dysfunction
by: Rama Devi Mittal, et al.
Published: (2003-01-01)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml−1
by: Ma-Ping Huang, et al.
Published: (2023-01-01)